Searle said on Friday that it plans to import remdesivir, which has shown promise in treating coronavirus patients, from neighbouring Bangladesh, as reported Yahoo!News.
The company said it had entered into an exclusive licensing and marketing agreement with Bangladesh's Beximco Pharmaceuticals, which is reportedly the first company to introduce the generic variant of the drug.
Ferozson's Pharma said recently that it would make the drug in Pakistan after signing a non-exclusive licensing pact with Gilead to make and sell the drug to 127 nations, but it warned that production could take "weeks."
Searle said the Bangladesh imports would ensure an immediate supply of the drug at an affordable price.
To read more NewsPoints articles, click here.